发明名称 BICYCLIC COMPOUNDS OR SALTS THEREOF FOR USE IN THE TREATMENT OF CANCER
摘要 <p>Provided is a novel bicyclic compound which has an HSP90 inhibitory effect and a carcinostatic effect. Also provided is a pharmaceutical agent which is based on the HSP90 inhibitory effect and is useful in the prevention and/or treatment of a disease involving HSP90, particularly, cancer. The present invention provides a compound represented by the following general formula (I) or a salt thereof wherein at least one of X 1 , X 2 , X 3 , and X 4 represents N or N-oxide and the rest thereof are the same or different and each represent C-R 2 ; any one or two of Y 1 , Y 2 , Y 3 , and Y 4 represent C-R 4 and the rest thereof are the same or different and each represent CH or N; R 1 represents an optionally substituted monocyclic or bicyclic unsaturated heterocyclic group having 1 to 4 heteroatoms selected from N, S, and O; R 2 represents a hydrogen atom, an optionally substituted alkyl group having 1 to 6 carbon atoms etc.; R 3 represents a hydrogen atom, -CO-R 5 etc.; R 4 represents a hydrogen atom, -CO-R 6 , -N(R 7 )(R 8 ) etc.; R 5 represents a hydroxyl group, an amino group etc.; R 6 represents a hydroxyl group etc.; R 7 and R 8 are the same or different and each represent a hydrogen atom, an optionally substituted alkyl group having 1 to 6 carbon atoms etc.; and R 9 represents an optionally substituted cycloalkyl group having 3 to 7 carbon atoms etc.</p>
申请公布号 EP2662357(A1) 申请公布日期 2013.11.13
申请号 EP20120732119 申请日期 2012.01.06
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 KITADE, MAKOTO;YAMASHITA, SATOSHI;OHKUBO, SHUICHI
分类号 C07D215/12;A61K31/4375;A61K31/4709;A61K31/4725;A61K31/497;A61K31/501;A61K31/506;A61K31/517;A61K31/5377;A61P35/00;A61P35/02;A61P43/00;C07D401/04;C07D401/14;C07D403/04;C07D403/14;C07D405/14;C07D413/04;C07D417/04;C07D471/04 主分类号 C07D215/12
代理机构 代理人
主权项
地址